Table 4:

Clinical characteristics, treatment strategy, and response in 13 patients with DAVF types with CVD

Case No.	Sex	Age (yr)	Cognard Type before SRS	Treatment	Cognard Type after Venoplasty/Stent	Treatment after SRS	Follow-Up Duration (mo)	Response
1	F	41	IIa+b	Venoplasty/stent	IIa	–	46	PR
2	M	63	IIa+b	Venoplasty	IIa	–	38	CR
3	M	56	IIa+b	Venoplasty/stent	IIa	–	19	PR^{^a}
4	M	45	IIa+b	–	NA	–	15	CR
5	F	63	IIa+b	Venoplasty/stent	IIa+b	–	10	PR^{^a}
6	M	73	IIa+b	–	NA	–	10	PR
7	M	17	IIa+b	Venoplasty/stent	IIa+b	–	6	PR
8	M	55	IIb	–	NA	–	5.6	PR
9	M	19	III	–	NA	TAE twice	17	PR
10	M	27	III	Venoplasty	IIa	–	27	CR^{^b}
11	M	12	III	–		–	13	CR
12	M	27	IV	–		–	27.6	PR
13	M	55	IV	–		–	NA	NA

Note:—TAE indicates transarterial embolization; CR, complete regression; PR, partial regression; –, no adjunct treatment was performed; NA, not available.
↵a Restenosis of sinus after venoplasty and stenting.
↵b Asymptomatic intracranial hemorrhage on MR imaging.